Mouse/Rat IGFBP2 enzyme-linked immunoassay kit

CAT: EM0082 Datasheet
Specification 96 Test
Sensitivity 0.34 pg/ml (50 μl);2.10 pg/ml (10 μl)
Standard Curve Range 2.74~2000 pg/ml
Standard Curve Gradient 7 Points/3 Folds
Number of Incubations 2
Detectable sample Liquid phase sample of soluble substances. For example: serum, plasma, cell culture supernatant, tissue grinding liquid, etc.
Sample Volume 50 μl/10 μl
Type Ready-to-Use
Operation Duration 120min
pg/ml O.D. Average Corrected
0.00 0.0100 0.0110 0.0105
2.74 0.0155 0.0156 0.0156 0.0051
8.23 0.0285 0.0280 0.0283 0.0178
24.69 0.0637 0.0649 0.0643 0.0538
74.07 0.1629 0.1648 0.1639 0.1534
222.22 0.4441 0.4554 0.4498 0.4393
666.67 1.1970 1.1810 1.1890 1.1785
2000.00 3.0930 3.0590 3.076 3.0655

Precision

Intra-assay Precision Inter-assay Precision
Sample Number S1 S2 S3 S1 S2 S3
22 22 22 6 6 6
Average(pg/ml) 39.7 202.4 650.3 40.3 216.9 672.3
Standard Deviation 2.6 9.3 28.9 1.6 6.6 15.8
Coefficient of Variation(%) 6.6 4.6 4.4 4.0 3.0 2.3

Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty-two times on one plate to assess intra-assay precision. Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.

Spike Recovery

The spike recovery was evaluated by spiking 3 levels of mouse/rat IGFBP2 into health mouse/rat serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 89% to 115% with an overall mean recovery of 97%.

Sample Values

Sample Matrix Sample Evaluated Range (ng/ml) Detectable (%) Mean of Detectable (ng/ml)
Mouse Serum3015.20-475.93100291.62
Rat Serum3011.30-20.8410016.53

Serum/Plasma – Thirty samples from apparently healthy mice and thirty samples from apparently healthy rats were evaluated for the presence of mouse/rat IGFBP2 in this assay. No medical histories were available for the donors. n.d. = non-detectable. Samples measured below the sensitivity are considered to be non-detectable.

Background: IGFBP2

The superfamily of insulin-like growth factor (IGF) binding proteins include the six high-affinity IGF binding proteins (IGFBP) and at least four additional low-affinity binding proteins referred to as IGFBP related proteins (IGFBP-rP). All IGFBP superfamily members are cysteine-rich proteins with conserved cysteine residues, which are clustered in the amino- and carboxy-terminal thirds of the molecule. IGFBPs modulate the biological activities of IGF proteins. Some IGFBPs may also have intrinsic bioactivity that is independent of their ability to bind IGF proteins. Post-translational modifications of IGFBP, including glycosylation, phosphorylation and proteolysis, have been shown to modify the affinities of the binding proteins to IGF. ALS (Acid Labile Subunit) is a liver-derived protein that exists in a ternary complex with Insulin-like Growth Factor (IGF)-binding Protein-3 (IGFBP-3) or IGFBP-5, and either IGF-I or IGF-II. ALS increases the half-life of IGF/IGFBP complexes in circulation.

Under construction!

Under construction!

Under construction!

Contact Information
Related Products
相关途径
Guarantee